Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Jan. 2, 1998

Commencement of phase II trials of LiquiVent for adult ARDS

Dec. 31, 1997

IL-5 receptor ligands reported by Glaxo Wellcome

Dec. 31, 1997

New treatment approach for nasal congestion

Dec. 30, 1997

TOBI approved by FDA for management of CF patients

Dec. 29, 1997

New antiallergic agents from Dainippon Ink & Chemicals

Dec. 29, 1997

Teijin starts clinical trials of in-licensed antiasthmatic drug

Dec. 24, 1997

Boehringer Ingelheim to develop and market Procysteine in Japan

Dec. 24, 1997

Jouveinal patents PDE IV inhibitors

Dec. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...